To Use or Not to Use a Self-monitoring of Blood Glucose System? Real-world Flash Glucose Monitoring Patterns Using a Cluster Analysis of the FGM-Japan Study.


Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
15 Sep 2023
Historique:
medline: 20 9 2023
pubmed: 12 1 2023
entrez: 11 1 2023
Statut: ppublish

Résumé

Objective This study investigated self-monitoring of blood glucose (SMBG) adherence and flash glucose monitoring patterns using a cluster analysis in Japanese type 1 diabetes (T1D) patients with intermittently scanned continuous glucose monitoring (isCGM). Methods We measured SMBG adherence and performed a data-driven cluster analysis using a hierarchical clustering in T1D patients from Japan using the FreeStyle Libre system. Clusters were based on three variables (testing glucose frequency and referred Libre data for hyperglycemia or hypoglycemia). Patients We enrolled 209 participants. Inclusion criteria were patients with T1D, duration of isCGM use ≥3 months, age ≥20 years old, and regular attendance at the collaborating center. Results The rate of good adherence to SMBG recommended by a doctor was 85.0%. We identified three clusters: cluster 1 (low SMBG test frequency but high reference to Libre data, 17.7%), cluster 2 (high SMBG test frequency but low reference to Libre data, 34.0%), and cluster 3 (high SMBG test frequency and high reference to Libra data, 48.3%). Compared with other clusters, individuals in cluster 1 were younger, those in cluster 2 had a shorter Libre duration, and individuals in cluster 3 had lower time-in-range, higher severe diabetic distress, and high intake of snacks and sweetened beverages. There were no marked differences in the incidence of diabetic complications and rate of wearing the Libre sensor among the clusters. Conclusion We stratified the patients into three subgroups with varied clinical characteristics and CGM metrics. This new substratification might help tailor diabetes management of patients with T1D using isCGM.

Identifiants

pubmed: 36631091
doi: 10.2169/internalmedicine.0639-22
pmc: PMC10569920
doi:

Substances chimiques

Blood Glucose 0
Hypoglycemic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2607-2615

Références

Sleep. 2019 Oct 9;42(10):
pubmed: 31361895
BMJ Open Diabetes Res Care. 2020 Aug;8(1):
pubmed: 32784247
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
J Diabetes Sci Technol. 2017 May;11(3):476-483
pubmed: 27807014
J Diabetes Investig. 2014 Feb 12;5(1):115-8
pubmed: 24843746
Diabet Med. 2018 Apr;35(4):472-482
pubmed: 29356072
Diabetes Technol Ther. 2005 Apr;7(2):253-63
pubmed: 15857227
Diabetes Technol Ther. 2018 Aug;20(8):557-560
pubmed: 30036082
Diabetes Res Clin Pract. 2016 Feb;112:65-72
pubmed: 26688058
Diabetes Metab Syndr. 2019 Sep - Oct;13(5):2923-2926
pubmed: 31425957
Diabetes Care. 2006 Nov;29(11):2433-8
pubmed: 17065680
Can J Diabetes. 2020 Aug;44(6):473-480
pubmed: 32360151
US Endocrinol. 2012 Summer;8(1):27-29
pubmed: 24312136
J Endocr Soc. 2018 Nov 14;2(12):1320-1337
pubmed: 30474069
Lancet. 2016 Nov 5;388(10057):2254-2263
pubmed: 27634581
J Diabetes Investig. 2020 Jan;11(1):5-16
pubmed: 31677343
Adv Ther. 2021 Jun;38(6):3314-3324
pubmed: 34009604
J Diabetes Sci Technol. 2021 Sep;15(5):1084-1092
pubmed: 32762345
Lancet. 2021 Jun 12;397(10291):2275-2283
pubmed: 34089660
Diabetes Ther. 2019 Jun;10(3):853-863
pubmed: 31037553
Diabetes Technol Ther. 2021 Sep;23(S3):S66-S71
pubmed: 34546081
Eur Endocrinol. 2018 Apr;14(1):24-29
pubmed: 29922348
Diabetes Technol Ther. 2020 Jul;22(7):509-515
pubmed: 32073311
Stat (Int Stat Inst). 2018;7(1):
pubmed: 29736237
Diabetes Technol Ther. 2017 May;19(S2):S27-S36
pubmed: 28541132
Intern Med J. 2022 Jun;52(6):1002-1008
pubmed: 33462994
Health Econ. 2002 Jun;11(4):341-53
pubmed: 12007165
J Diabetes Investig. 2012 Dec 20;3(6):536-9
pubmed: 24843620
Eur Heart J. 2012 Feb;33(4):467-77
pubmed: 22334626
Diabetes Care. 1997 May;20(5):760-6
pubmed: 9135939
Intern Med. 2018 Dec 1;57(23):3345-3350
pubmed: 30101924
Diabetes Metab Syndr Obes. 2019 Nov 28;12:2461-2477
pubmed: 31819572
Diabetes Care. 2017 Dec;40(12):1631-1640
pubmed: 29162583
Lancet Diabetes Endocrinol. 2018 May;6(5):361-369
pubmed: 29503172
J Diabetes Sci Technol. 2019 May;13(3):575-583
pubmed: 30453761
Diabetes Care. 2021 Jun;44(6):1368-1376
pubmed: 33879536
Pediatr Diabetes. 2018 Nov;19(7):1285-1293
pubmed: 30022571
J Epidemiol. 2020 Feb 5;30(2):57-66
pubmed: 30828034
Diabetes Care. 1987 Sep-Oct;10(5):617-21
pubmed: 3677982
Eur Endocrinol. 2016 Mar;12(1):24-30
pubmed: 29632583
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Diabetes Care. 2018 Nov;41(11):2265-2274
pubmed: 30348844
Diabetes Technol Ther. 2020 Mar;22(3):235-238
pubmed: 31833786
Diabetes Obes Metab. 2018 Jun;20(6):1503-1507
pubmed: 29381253

Auteurs

Naoki Sakane (N)

Division of Preventive Medicine, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.

Yushi Hirota (Y)

Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan.

Akane Yamamoto (A)

Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan.

Junnosuke Miura (J)

Diabetes Center, Tokyo Women's Medical University School of Medicine, Japan.

Hiroko Takaike (H)

Diabetes Center, Tokyo Women's Medical University School of Medicine, Japan.

Sari Hoshina (S)

Diabetes Center, Tokyo Women's Medical University School of Medicine, Japan.

Masao Toyoda (M)

Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Japan.

Nobumichi Saito (N)

Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Japan.

Kiminori Hosoda (K)

Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, Japan.

Masaki Matsubara (M)

Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, Japan.
Department of General Medicine, Nara Medical University, Japan.

Atsuhito Tone (A)

Department of Internal Medicine, Okayama Saiseikai General Hospital, Japan.

Satoshi Kawashima (S)

Kanda Naika Clinic, Japan.

Hideaki Sawaki (H)

Sawaki Internal Medicine and Diabetes Clinic, Japan.

Tomokazu Matsuda (T)

Matsuda Diabetes Clinic, Japan.

Masayuki Domichi (M)

Division of Preventive Medicine, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.

Akiko Suganuma (A)

Division of Preventive Medicine, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.

Seiko Sakane (S)

Division of Preventive Medicine, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.

Takashi Murata (T)

Department of Clinical Nutrition, National Hospital Organization Kyoto Medical Center, Japan.
Diabetes Center, National Hospital Organization Kyoto Medical Center, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH